These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 32410794)

  • 21. [Clinicopathological characteristics and prognostic factors of breast cancer with estrogen- and progesterone-receptor negative and HER-2 overexpression].
    Fan Y; Guan Y; Zhao WH; Li Q; Xu BH
    Zhonghua Zhong Liu Za Zhi; 2008 Dec; 30(12):917-20. PubMed ID: 19173993
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gene expression profiling for guiding adjuvant chemotherapy decisions in women with early breast cancer: an evidence-based and economic analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(23):1-57. PubMed ID: 23074401
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adherence to National Comprehensive Cancer Network Guidelines for
    Bobbili P; Olufade T; DerSarkissian M; Shenolikar R; Yu H; Duh MS; Tung N
    Hered Cancer Clin Pract; 2020; 18():13. PubMed ID: 32518611
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Familial breast cancer: characteristics and outcome of BRCA 1-2 positive and negative cases.
    Veronesi A; de Giacomi C; Magri MD; Lombardi D; Zanetti M; Scuderi C; Dolcetti R; Viel A; Crivellari D; Bidoli E; Boiocchi M
    BMC Cancer; 2005 Jul; 5():70. PubMed ID: 15996267
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changing Patterns in Clinicopathological Characteristics of Breast Cancer and Prevalence of
    Wang Q; Wu H; Lan Y; Zhang J; Wu J; Zhang Y; Li L; Liu D; Zhang J
    Int J Gen Med; 2021; 14():7371-7380. PubMed ID: 34744450
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genomic Profiling Comparison of Germline
    Huang X; Shao D; Wu H; Zhu C; Guo D; Zhou Y; Chen C; Lin Y; Lu T; Zhao B; Wang C; Sun Q
    Front Oncol; 2020; 10():583314. PubMed ID: 33194720
    [No Abstract]   [Full Text] [Related]  

  • 27. Preoperative genetic testing affects surgical decision making in breast cancer patients.
    Lokich E; Stuckey A; Raker C; Wilbur JS; Laprise J; Gass J
    Gynecol Oncol; 2014 Aug; 134(2):326-30. PubMed ID: 24910453
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cisplatin with veliparib or placebo in metastatic triple-negative breast cancer and BRCA mutation-associated breast cancer (S1416): a randomised, double-blind, placebo-controlled, phase 2 trial.
    Rodler E; Sharma P; Barlow WE; Gralow JR; Puhalla SL; Anders CK; Goldstein L; Tripathy D; Brown-Glaberman UA; Huynh TT; Szyarto CS; Godwin AK; Pathak HB; Swisher EM; Radke MR; Timms KM; Lew DL; Miao J; Pusztai L; Hayes DF; Hortobagyi GN
    Lancet Oncol; 2023 Feb; 24(2):162-174. PubMed ID: 36623515
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Evaluation of the predictive effect of PD-L1 expression on survival in early triple-negative breast cancer].
    Yue J; Wang X; Zhu AJ; Wang DY; Gao SL; Hu NL; Si YR; Zheng FC; Ju J; Wang Z; Yuan P
    Zhonghua Zhong Liu Za Zhi; 2023 Nov; 45(11):948-954. PubMed ID: 37968080
    [No Abstract]   [Full Text] [Related]  

  • 30. Prevalence of BRCA1 and BRCA2 Mutations Among High-risk Bahraini Patients with Breast Cancer.
    Bukamal Z; AlRayes A
    Gulf J Oncolog; 2023 May; 1(42):22-25. PubMed ID: 37283256
    [TBL] [Abstract][Full Text] [Related]  

  • 31.
    Huszno J; Kołosza Z; Grzybowska E
    Oncol Lett; 2019 Feb; 17(2):1986-1995. PubMed ID: 30675265
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinicopathological features and prognosis of bilateral breast cancer: a single-center cohort study based on Chinese data.
    Hong C; Zheng Y; Geng R; Hu H; Zhong Y; Guan Q; Zhang Y; Li X
    Ann Transl Med; 2022 Jul; 10(13):742. PubMed ID: 35957718
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of tumor-infiltrating lymphocytes and association with prognosis in BRCA-mutated breast cancer.
    Sønderstrup IMH; Jensen MB; Ejlertsen B; Eriksen JO; Gerdes AM; Kruse TA; Larsen MJ; Thomassen M; Laenkholm AV
    Acta Oncol; 2019 Mar; 58(3):363-370. PubMed ID: 30614364
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Germline BRCA mutation and outcome in young-onset breast cancer (POSH): a prospective cohort study.
    Copson ER; Maishman TC; Tapper WJ; Cutress RI; Greville-Heygate S; Altman DG; Eccles B; Gerty S; Durcan LT; Jones L; Evans DG; Thompson AM; Pharoah P; Easton DF; Dunning AM; Hanby A; Lakhani S; Eeles R; Gilbert FJ; Hamed H; Hodgson S; Simmonds P; Stanton L; Eccles DM
    Lancet Oncol; 2018 Feb; 19(2):169-180. PubMed ID: 29337092
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Germline breast cancer susceptibility gene mutations and breast cancer outcomes.
    Wang YA; Jian JW; Hung CF; Peng HP; Yang CF; Cheng HS; Yang AS
    BMC Cancer; 2018 Mar; 18(1):315. PubMed ID: 29566657
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparing Prognosis for
    Antunes Meireles P; Fragoso S; Duarte T; Santos S; Bexiga C; Nejo P; Luís A; Mira B; Miguel I; Rodrigues P; Vaz F
    Cancers (Basel); 2023 Dec; 15(23):. PubMed ID: 38067403
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of the indication of BRCA1/2 genetic tests in Iranian women and acceptance rate of risk-reducing surgeries in BRCA mutation carriers.
    Vasigh M; Eslami B; Elahi A; Kaviani A; Shirkoohi R; Majidzadeh K; Nazarian N; Omranipour R
    Mol Genet Genomic Med; 2022 Feb; 10(2):e1867. PubMed ID: 35023322
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The spectrum of BRCA mutations and characteristics of BRCA-associated breast cancers in China: Screening of 2,991 patients and 1,043 controls by next-generation sequencing.
    Lang GT; Shi JX; Hu X; Zhang CH; Shan L; Song CG; Zhuang ZG; Cao AY; Ling H; Yu KD; Li S; Sun MH; Zhou XY; Huang W; Shao ZM
    Int J Cancer; 2017 Jul; 141(1):129-142. PubMed ID: 28294317
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinicopathological characteristics and prognosis of early-stage HER2 low-expression breast cancer: A single-center retrospective study.
    Liu CG; Li YF; Ma TY; Lv M; Lv ZD; Wang YY; Liu XP; Mao Y; Wang HB
    Front Oncol; 2023; 13():1130734. PubMed ID: 37064133
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improved survival in non-Ashkenazi Jewish ovarian cancer patients with BRCA1 and BRCA2 gene mutations.
    Lacour RA; Westin SN; Meyer LA; Wingo SN; Schorge JO; Brooks R; Mutch D; Molina A; Sutphen R; Barnes M; Elder J; Teoh D; Powell CB; Choubey V; Blank S; Macdonald HR; Brady MF; Urbauer DL; Bodurka D; Gershenson DM; Lu KH
    Gynecol Oncol; 2011 May; 121(2):358-63. PubMed ID: 21276604
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.